Rheumatoid Arthritis

Showing NaN - NaN of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Adalimumab, Upadacitinib Matching Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Flagstaff, Arizona
  • +190 more
Apr 4, 2023

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Exactech Shoulder Post Market Clinical Follow-up Study

Recruiting
  • Osteo Arthritis Shoulders
  • +8 more
    • Laguna Woods, California
    • +33 more
    Jan 27, 2023

    Rheumatoid Arthritis Trial in United States (Baricitinib, TNF Inhibitor)

    Recruiting
    • Rheumatoid Arthritis
    • Flagstaff, Arizona
    • +108 more
    Jan 17, 2023

    Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

    Completed
    • Rheumatoid Arthritis
    • ISIS 104838
    • Birmingham, Alabama
    • +30 more
    Dec 1, 2022

    Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)

    Completed
    • Rheumatoid Arthritis
    • Huntsville, Alabama
    • +152 more
    Aug 30, 2022

    Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

    Active, not recruiting
    • Rheumatoid Arthritis
    • Placebo for Adalimumab
    • +3 more
    • Birmingham, Alabama
    • +369 more
    Jun 14, 2022

    Rheumatoid Arthritis Trial in United States (Experimental: Arm A: DRL_RI, Arm B: Rituxan®/Mabthera®)

    Active, not recruiting
    • Rheumatoid Arthritis
    • Experimental: Arm A: DRL_RI
    • Arm B: Rituxan®/Mabthera®
    • Phoenix, Arizona
    • +25 more
    Apr 6, 2022

    Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))

    Completed
    • Rheumatoid Arthritis
    • SAR153191 (REGN88)
    • Anniston, Alabama
    • +334 more
    Mar 21, 2022

    Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))

    Completed
    • Rheumatoid Arthritis
    • Covina, California
    • +85 more
    Mar 15, 2022

    Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Huntsville, Alabama
    • +187 more
    Feb 14, 2022

    Rheumatoid Arthritis Trial in Worldwide (Olokizumab, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Glendale, Arizona
    • +164 more
    Jun 30, 2021

    Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)

    Completed
    • Rheumatoid Arthritis
    • Huntsville, Alabama
    • +200 more
    Jun 25, 2021

    Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)

    Completed
    • Rheumatoid Arthritis
    • Olokizumab 64mg q4w
    • +3 more
    • Mesa, Arizona
    • +244 more
    Apr 6, 2021

    Rheumatoid Arthritis Trial in United States (ATI-450, Placebo oral tablet, Methotrexate)

    Completed
    • Rheumatoid Arthritis
    • Anniston, Alabama
    • +4 more
    Mar 24, 2021

    Rheumatoid Arthritis Trial in Worldwide (etanercept pre-filled syringe subcutaneous injection, Oral methotrexate, Placebo for

    Completed
    • Rheumatoid Arthritis
    • etanercept pre-filled syringe subcutaneous injection
    • +4 more
    • Birmingham, Alabama
    • +135 more
    Nov 24, 2020

    Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CDP870))

    Completed
    • Rheumatoid Arthritis
    • Certolizumab pegol (CDP870)
    • Huntsville, Alabama
    • +78 more
    Nov 26, 2020

    Rheumatoid Arthritis Trial in Worldwide (SKI-O-703, Placebo)

    Unknown status
    • Rheumatoid Arthritis
    • Beverly Hills, California
    • +39 more
    Oct 8, 2020

    Rheumatoid Arthritis Trial in Worldwide (M2591 25 mg QD, M2951 75 mg QD, M2951 50 mg BID)

    Completed
    • Rheumatoid Arthritis
    • M2591 25 mg QD
    • +3 more
    • Phoenix, Arizona
    • +97 more
    Sep 4, 2020

    Rheumatoid Arthritis Trial in Australia, United States (Allogeneic Mesenchymal Precursor Cells, Normal Saline)

    Completed
    • Rheumatoid Arthritis
    • Allogeneic Mesenchymal Precursor Cells
    • Normal Saline
    • Anniston, Alabama
    • +22 more
    Jun 25, 2020

    Rheumatoid Arthritis Trial in Worldwide (GDC-0853, Adalimumab, Folic Acid)

    Completed
    • Rheumatoid Arthritis
    • Anniston, Alabama
    • +149 more
    Jun 1, 2020

    Rheumatoid Arthritis Trial in Worldwide (Apremilast 30 mg, Apremilast 20 mg, Placebo)

    Terminated
    • Rheumatoid Arthritis
    • Apremilast 30 mg
    • +2 more
    • Gilbert, Arizona
    • +49 more
    Apr 22, 2020

    Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)

    Completed
    • Rheumatoid Arthritis
    • Certolizumab Pegol
    • Huntsville, Alabama
    • +120 more
    Mar 16, 2020

    Rheumatoid Arthritis Trial in Worldwide (SAIT101, MabThera, Rituxan)

    Completed
    • Rheumatoid Arthritis
    • SAIT101
    • +2 more
    • Anniston, Alabama
    • +74 more
    Feb 4, 2020

    Rheumatoid Arthritis Trial in Worldwide (CP-690,550, Methotrexate, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Huntsville, Alabama
    • +135 more
    Nov 13, 2019